Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Haller

Showing results (511-520 of 570) with videos related to

Pageof 57
Sort By:
Journal of the American Society of Nephrology : JASN|October 28, 2021
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b TrialKlemens Budde, Rohini Prashar, Hermann Haller, et al.
Nature Communications|October 18, 2017
Blood vessel control of macrophage maturation promotes arteriogenesis in ischemiaKashyap Krishnasamy, Anne Limbourg, Tamar Kapanadze, et al.
American Journal of Physiology. Renal Physiology|January 24, 2018
Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosisRobert Greite, Anja Thorenz, Rongjun Chen, et al.
The American Journal of Pathology|November 5, 2002
Immunosuppressive treatment protects against angiotensin II-induced renal damageDominik N Muller, Erdenechimeg Shagdarsuren, Joon-Keun Park, et al.
International Journal of Molecular Sciences|May 30, 2019
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft RejectionLena Schiffer, Flavia Wiehler, Jan Hinrich Bräsen, et al.
American Journal of Nephrology|January 17, 2015
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathyLuis M Ruilope, Rajiv Agarwal, Juliana C Chan, et al.
Scientific Reports|February 23, 2018
Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injuryMalte Kölling, Celina Genschel, Tamas Kaucsar, et al.
Journal of the American Society of Nephrology : JASN|May 24, 2014
MicroRNA-24 antagonism prevents renal ischemia reperfusion injuryJohan M Lorenzen, Tamas Kaucsar, Celina Schauerte, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 19, 2016
Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantationKatja Hueper, Abedalrazag A Khalifa, Jan H Bräsen, et al.
Circulation|April 2, 2003
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidaseRalf Dechend, Christiane Viedt, Dominik N Müller, et al.
Pageof 57

Showing results (511-520 of 570) with videos related to

Sort By:
Pageof 57
Journal of the American Society of Nephrology : JASN|October 28, 2021
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b TrialKlemens Budde, Rohini Prashar, Hermann Haller, et al.
Nature Communications|October 18, 2017
Blood vessel control of macrophage maturation promotes arteriogenesis in ischemiaKashyap Krishnasamy, Anne Limbourg, Tamar Kapanadze, et al.
American Journal of Physiology. Renal Physiology|January 24, 2018
Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosisRobert Greite, Anja Thorenz, Rongjun Chen, et al.
The American Journal of Pathology|November 5, 2002
Immunosuppressive treatment protects against angiotensin II-induced renal damageDominik N Muller, Erdenechimeg Shagdarsuren, Joon-Keun Park, et al.
International Journal of Molecular Sciences|May 30, 2019
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft RejectionLena Schiffer, Flavia Wiehler, Jan Hinrich Bräsen, et al.
American Journal of Nephrology|January 17, 2015
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathyLuis M Ruilope, Rajiv Agarwal, Juliana C Chan, et al.
Scientific Reports|February 23, 2018
Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injuryMalte Kölling, Celina Genschel, Tamas Kaucsar, et al.
Journal of the American Society of Nephrology : JASN|May 24, 2014
MicroRNA-24 antagonism prevents renal ischemia reperfusion injuryJohan M Lorenzen, Tamas Kaucsar, Celina Schauerte, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 19, 2016
Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantationKatja Hueper, Abedalrazag A Khalifa, Jan H Bräsen, et al.
Circulation|April 2, 2003
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidaseRalf Dechend, Christiane Viedt, Dominik N Müller, et al.
Pageof 57